<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35580297</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1527-7755</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</Title>
          <ISOAbbreviation>J Clin Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations.</ArticleTitle>
        <Pagination>
          <StartPage>JCO2102641</StartPage>
          <MedlinePgn>JCO2102641</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1200/JCO.21.02641</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Aumolertinib (formerly almonertinib; HS-10296) is a novel third-generation epidermal growth factor receptor tyrosine kinase inhibitor approved in China. This double-blind phase III trial evaluated the efficacy and safety of aumolertinib compared with gefitinib as a first-line treatment for locally advanced or metastatic <i>EGFR</i>-mutated non-small-cell lung cancer (NSCLC; ClinicalTrials.gov identifier: NCT03849768).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Patients at 53 sites in China were randomly assigned 1:1 to receive either aumolertinib (110 mg) or gefitinib (250 mg) once daily. The primary end point was progression-free survival (PFS) per investigator assessment.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 429 patients who were naïve to treatment for locally advanced or metastatic NSCLC were enrolled. PFS was significantly longer with aumolertinib compared with gefitinib (hazard ratio, 0.46; 95% CI, 0.36 to 0.60; <i>P</i> &lt; .0001). The median PFS with aumolertinib was 19.3 months (95% CI, 17.8 to 20.8) versus 9.9 months with gefitinib (95% CI, 8.3 to 12.6). Objective response rate and disease control rate were similar in the aumolertinib and gefitinib groups (objective response rate, 73.8% and 72.1%, respectively; disease control rate, 93.0% and 96.7%, respectively). The median duration of response was 18.1 months (95% CI, 15.2 to not applicable) with aumolertinib versus 8.3 months (95% CI, 6.9 to 11.1) with gefitinib. Adverse events of grade ≥ 3 severity (any cause) were observed in 36.4% and 35.8% of patients in the aumolertinib and gefitinib groups, respectively. Rash and diarrhea (any grade) were observed in 23.4% and 16.4% of patients who received aumolertinib compared with 41.4% and 35.8% of those who received gefitinib, respectively.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Aumolertinib is a well-tolerated third-generation epidermal growth factor receptor tyrosine kinase inhibitor that could serve as a treatment option for <i>EGFR</i>-mutant NSCLC in the first-line setting.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Shun</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-8833-7262</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Xiaorong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jian</LastName>
            <ForeName>Hong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jianhua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology-Chest, Hunan Cancer Hospital &amp; The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Gongyan</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Thoracic Oncology Medicine, Harbin Medical University Cancer Hospital, Harbin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Yuping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Jinan Central Hospital, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ji</LastName>
            <ForeName>Yinghua</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Ziping</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chest Medicine, Beijing Cancer Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Jianhua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Linyi Cancer Hospital, Linyi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Junguo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Respiratory Medicine, Nantong Tumor Hospital, Nantong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Shaoshui</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Binzhou Medical University Hospital, Binzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Dongqing</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Breath Internal Medicine, Taizhou Hospital of Zhejiang Province, Linhai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Guojun</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiration, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Chunling</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Lung Internal Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Oncology, Sichuan Cancer Hospital, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Xinmin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Zhong</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Oncology, The Fifth Subsidiary Sun Yat-sen University Hospital, Zhuhai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Zhuang</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0003-1676-135X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zhehai</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Shandong Cancer Hospital, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Jiuwei</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The First Bethune Hospital of Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Xingxiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiration, Northern Jiangsu People's Hospital, The Affiliated Hospital to Yangzhou University, Yangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chest Medicine, Beijing Cancer Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Jifeng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiration, Xinqiao Hospital, The Second Affiliated Hospital of China PLA Army Medical University, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chest Internal Medicine, Liaoning Cancer Hospital &amp; Institute, Shenyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Nong</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Lung &amp; Gastrointestinal Oncology Department, Hunan Cancer Hospital (The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University), Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Xiangdong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Critical Care Medicine, the Southwest Hospital of AMU, The First Affiliated Hospital of PLA Army Medical University, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiaohong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Chengping</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Respiratory Medicine, Xiangya Hospital Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Zhihong</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiration Oncology, Anhui Provincial Cancer Hospital, Hefei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>You</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0003-1671-1408</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yanping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Liyan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiration, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qiming</ForeName>
            <Initials>Q</Initials>
            <Identifier Source="ORCID">0000-0002-7813-2885</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Respiration, Henan Cancer Hospital, Zhengzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Renhua</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Jiangsu Province Hospital, Nanjing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Jianying</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Baolan</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology Internal Medicine, Beijing Chest Hospital, Capital Medical Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Chunhong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Xiangya Second Hospital of Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tong</LastName>
            <ForeName>Wancheng</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infection Internal Medicine, Nanfang Hospital, Nanfang Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Helong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The Second Affiliated Hospital of Air Force Military Medical University, Xi'An, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiration, The First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yuan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Tongji Medical College Huazhong University of Science &amp; Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jie</LastName>
            <ForeName>Zhijun</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yao</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology Internal Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Longzhen</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Radiotherapy Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jie</LastName>
            <ForeName>Weng</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Yueyang Central Hospital, Yueyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Weidong</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiong</LastName>
            <ForeName>Jianping</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ye</LastName>
            <ForeName>Xianwei</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory and Critical Care Medicine, GuiZhou Provincial People's Hospital, Guiyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duan</LastName>
            <ForeName>Jianchun</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-3300-1707</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Haihua</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-5549-8633</Identifier>
            <AffiliationInfo>
              <Affiliation>Radiotherapy Section, Taizhou Hospital of Zhejiang Province, Linhai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Meili</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology Internal Medicine, Jinan Central Hospital Affiliated to Shandong University, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Changan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Hongying</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chuan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Siraj M</ForeName>
            <Initials>SM</Initials>
            <Identifier Source="ORCID">0000-0001-7477-4023</Identifier>
            <AffiliationInfo>
              <Affiliation>EQRx, Inc, Cambridge, MA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miller</LastName>
            <ForeName>Vincent A</ForeName>
            <Initials>VA</Initials>
            <AffiliationInfo>
              <Affiliation>EQRx, Inc, Cambridge, MA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Qiong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT03849768</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Oncol</MedlineTA>
        <NlmUniqueID>8309333</NlmUniqueID>
        <ISSNLinking>0732-183X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CoiStatement><b>Shun Lu</b><b>Consulting or Advisory Role:</b> AstraZeneca, Pfizer, Boehringer Ingelheim, Hutchison MediPharma, Simcere Pharmaceutical Group, Zai Lab, GenomiCare, Yuhan, Prime Oncology, Roche<b>Speakers' Bureau:</b> AstraZeneca, Roche, Hansoh Pharma, Hengrui Therapeutics<b>Research Funding:</b> AstraZeneca (Inst), Hutchison MediPharma (Inst), BMS (Inst), Hengrui Therapeutics (Inst), BeiGene (Inst), Roche (Inst) <b>Xiaorong Dong</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Yuping Sun</b><b>Honoraria:</b> Roche, Pfizer, AstraZeneca<b>Consulting or Advisory Role:</b> AstraZeneca, Roche<b>Research Funding:</b> Roche, Pfizer <b>Yinghua Ji</b><b>Research Funding:</b> AoSaikang, CSPC Pharma, Hualan Bio (Inst) <b>Jianhua Shi</b><b>Honoraria:</b> Roche, BeiGene<b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Junguo Lu</b><b>Research Funding:</b> Hansoh (Inst), Akesobio (Inst), Shanghai Henlius Biotech (Inst) <b>Shaoshui Chen</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Xinmin Yu</b><b>Research Funding:</b> BeiGene, Innovent Biologics, BMS, MSD, Hansoh <b>Zhehai Wang</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Xingxiang Xu</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Jian Fang</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Yanping Hu</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Nong Yang</b><b>Consulting or Advisory Role:</b> Hansoh Pharmaceutical Group Co, Ltd<b>Research Funding:</b> Hansoh Pharmaceutical Group Co, Ltd <b>Xiangdong Zhou</b><b>Research Funding:</b> MSD, AZ, Hansoh, Hengrui, Sanofi, J&amp;J, BMS, BeiGene, Pfizer, GSK, Novartis, Chiesi (Inst) <b>You Lu</b><b>Honoraria:</b> Roche/Genentech, AstraZeneca, Pfizer, Bristol Myers Squibb, Merck Sharp &amp; Dohme, BeiGene<b>Consulting or Advisory Role:</b> Roche/Genentech, AstraZeneca, Pfizer, Bristol Myers Squibb, Merck Sharp &amp; Dohme, BeiGene <b>Qiming Wang</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Jianying Zhou</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Yuan Chen</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Haihua Yang</b><b>Consulting or Advisory Role:</b> Hansoh Pharma<b>Research Funding:</b> Hansoh Pharma (Inst) <b>Changan Sun</b><b>Employment:</b> Jiangsu Hansoh Pharmaceutical Group Co, Ltd<b>Leadership:</b> Jiangsu Hansoh Pharmaceutical Group Co, Ltd <b>Hongying Wei</b><b>Employment:</b> Hansoh Pharma <b>Chuan Li</b><b>Employment:</b> Hansoh Pharma <b>Siraj M. Ali</b><b>Employment:</b> EQRX, EQRX<b>Leadership:</b> Incysus, Elevation Oncology, Pillar Biosciences, Droplet Biosciences<b>Stock and Other Ownership Interests:</b> Exelixis, Merus NV, Pfizer, Pfizer<b>Consulting or Advisory Role:</b> Azitra, Princeptx, Archer<b>Patents, Royalties, Other Intellectual Property:</b> patents via Foundation Medicine, patents via Seres Health on microbiome stuff in non-neoplastic disease <b>Vincent A. Miller</b><b>Employment:</b> Foundation Medicine, EQRX<b>Leadership:</b> Revolution Medicines<b>Stock and Other Ownership Interests:</b> Foundation Medicine, Mirati Therapeutics, Revolution Medicines, EQRX<b>Patents, Royalties, Other Intellectual Property:</b> Received periodic royalties related to T790M patent awarded to the Memorial Sloan Kettering Cancer Center <b>Qiong Wu</b><b>Employment:</b> Hansoh PharmaNo other potential conflicts of interest were reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>16</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35580297</ArticleId>
        <ArticleId IdType="doi">10.1200/JCO.21.02641</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
